Clinical Trial Update: SHR-1701 in Patients With Recurrent/Metastatic Scchn [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SHR-1701 in recurrent/metastatic squamous cell carcinoma of the head and neck.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• SHR-1701

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: UNKNOWN